JULIE BELL CONSULTING LIMITED

Financial Health Score: B+ (Strong Recovery with Historical Volatility)

The company has demonstrated a remarkable recovery in the latest financial year, transitioning from a period of thin equity to a robust capital position. The ability to generate significant implied profits while distributing substantial dividends to the owner is the financial equivalent of a clean bill of health. However, the grade is held back slightly by a history of volatility and a lingering reliance on director support during the year, suggesting the business must maintain its fitness regimen to avoid future relapses.

1. Key Vital Signs

• Net Assets (The Business's "Muscle Mass"): £22,171 (up from £3,735 in 2024). This is a substantial 493% increase in underlying equity. The business has rapidly rebuilt its reserves after a period of depletion.
• Current Assets vs. Current Liabilities (The "Blood Pressure"): £49,979 (Current Assets + Prepayments) vs. £27,247 (Creditors due within one year). This yields a healthy current ratio of approximately 1.8:1. The company has good short-term liquidity and is not struggling to meet its immediate obligations.
• Implied Profitability (The "Metabolic Rate"): While the Profit & Loss account is not filed (as permitted for micro-entities), we can deduce a strong metabolic rate. Net assets increased by £18,436, and the company paid out £38,000 in dividends. This implies a pre-dividend profit generation of roughly £56,000 for the year—a very healthy return for a micro-consultancy.
• Director's Loan Activity (The "IV Drip"): Director J. Cullen injected £39,480 into the business during the year but subsequently withdrew £2,437 in repayments and £38,000 in dividends, leaving the loan account clear. This shows the director provided short-term working capital ("hydration") which was successfully flushed through the system and repaid once cash flow normalized.

2. Symptoms Analysis

Looking under the surface, the data reveals specific symptoms about the underlying business health:

• Symptom: Historical Weakness (2016-2020): The company's net assets peaked in 2016 at £63,485 before steadily declining to a negative position of -£3,887 in 2020. This indicates a prolonged period of "financial illness" where the business was consuming its own reserves, likely due to revenue drops or margin pressures.
• Symptom: The 2025 "Rebound": The latest year shows the patient has not only recovered but is thriving. The sharp increase in Current Assets (from £32k to £52k) suggests a strong influx of cash or debtor payments, effectively flushing out the prior weakness.
• Symptom: Director Dependency: The significant short-term loan from Director J. Cullen at the start of the year (£39,480 advanced) suggests the business required a cash injection to fund operations or working capital. However, the fact that this was cleared by year-end, alongside a £38,000 dividend payout, confirms the injection was a temporary bridge rather than a long-term crutch.

3. Diagnosis

Diagnosis: Acute Recovery and Remission

The patient has moved from a state of financial fragility to one of robust health. The core diagnosis is a successful turnaround. The consultancy model is clearly generating strong cash flow in the short term, capable of funding both the repayment of director loans and a significant dividend extraction.

However, the business suffers from "Key Person Dependency Syndrome." As a micro-consultancy with only two employees (likely the directors), the financial health is entirely tied to the principals' ability to bill for their time. The volatility seen between 2016 and 2024 (assets swinging from £63k down to negative, and back up) suggests the business is susceptible to "feast or famine" cycles typical of small consultancies.

4. Recommendations

To maintain this improved health and prevent future relapses, the following financial wellness prescriptions are recommended:

1. Build a Financial Immune System (Cash Buffer): While current liquidity is healthy, the company should aim to retain a minimum of 3-6 months of operating expenses in cash reserves. This will prevent the need for future director loans (the "IV drip") during leaner months and protect against the volatility seen in previous years.
2. Monitor "Working Capital Heart Rate": The increase in Current Assets is positive, but it's important to monitor the split between Cash and Trade Debtors. If the £49k+ in current assets is mostly unpaid invoices, the business is at risk of a "blockage" (bad debt). Ensure credit control remains vigorous.
3. Diversify the Revenue Diet: To reduce the volatility inherent in a two-person consultancy, explore ways to productize services or secure retainer agreements. This smooths out the "feast or famine" cycle that has historically caused net assets to fluctuate.
4. Tax Health Check on Director Loans: The director loan activity involved interest charges (shifting from 2.25% to 3.75%). Ensure all compliance regarding director loan accounts (particularly the Section 455 tax implications if the loan exceeds £10k at any point) is strictly observed to avoid HMRC penalties.